We aim to develop and validate our diagnostic platform as well as our diagnostic service for Alzheimer’s Disease by conducting several multicentric studies across the country with the highest qualitative and ethical standards.
In our current clinical studies, we focus on the biomarker profile of healthy subjects and patients with brain pathologies, such as Alzheimer’s. Following patient examination and comparison of the results to the current clinical standard, we collaborate with renowned clinical centers and leading Alzheimer’s institutes. This enables us to benefit from an outstanding scientific expertise.
Our clinical trials are partly funded by BMBF (German Federal Ministry of Education and Research).
